Yann Echelard

All filings by Yann Echelard on record concern TG Therapeutics, Inc., in the capacity of board member. The record holds 19 filings, for trades running from 15 March 2013 to 24 November 2025.

Market trades split into 1 purchase (€91k) and 4 sales (€1.9M). Taken together, the sales exceed the purchases by €1.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 14 share grants. 2025 to date brings no purchases and 2 sales.

The record was last updated on 25 November 2025 with an open-market sale (€142k) in TG Therapeutics, Inc. The last insider purchase was made public on 6 January 2023, 1,389 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.